Work

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

Year: 2008

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-008-0756-0

Authors: Paula M. Fracasso, Joel Picus, Jonathan D. Wildi, Sherry A. Goodner, Allison N. Creekmore, Feng Gao, Ramaswamy Govindan, Matthew J. Ellis, Benjamin R. Tan, Gerald P. Linette, ChauHwei J. Fu, Helen S. Pentikis, Stephen C. Zumbrun, Merrill J. Egorin, Robert E. Bellet

Institutions: Washington University in St. Louis, University of Virginia Health System, Alvin J. Siteman Cancer Center, Icon (United States), University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Alvin J. Siteman Cancer Center

OpenAlex ID: W2066923209

FWCI: 1.694

Cites: 30

Cited by: 52

Related to: 10